FDA 483 - Nippon Protein Co., Ltd. Ashikaga Plant - June 27, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Nippon Protein Co., Ltd. Ashikaga Plant, an API manufacturer in Japan, received a Form 483 with three observations during an FDA inspection from June 23-27, 2025. The observations primarily concern failures in quality control systems, including inadequate investigations into discrepancies, lack of cleaning validation, and insufficient equipment qualification processes. These issues indicate a moderate level of concern regarding the firm's adherence to good manufacturing practices.
ID · 634252ef-80f9-46ea-b6ce-40a925e2f8e3